Abiopharma

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis

TD SYNNEX Reports Record Fiscal 2026 Second Quarter Results

Dollar Tree Announces Secondary Block Trade by Selling Stockholders and Share Buyback

Uxin Highlights Operational Strength and Long-Term Growth Strategy at 2026 Investor Day

Satellos to Present Clinical Program Updates at ICNMD 2026

Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani

Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026